4//SEC Filing
Schneiderman Daniel H 4
Accession 0001140361-22-000298
CIK 0001604191other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 9:07 PM ET
Size
5.3 KB
Accession
0001140361-22-000298
Insider Transaction Report
Form 4
Schneiderman Daniel H
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock option (right to buy)
2022-01-03+10,000→ 10,000 totalExercise: $1.45Exp: 2032-01-03→ Common stock, par value $0.0001 per share (10,000 underlying)
Footnotes (1)
- [F1]The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on the date of grant, conditioned on Mr. Schneiderman's continued employment by First Wave BioPharma, Inc. on the applicable vesting date.
Documents
Issuer
First Wave BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001565536
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 9:07 PM ET
- Size
- 5.3 KB